1994
DOI: 10.1007/978-1-4615-2632-2_9
|View full text |Cite
|
Sign up to set email alerts
|

Role of gene amplification in drug resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
5
0

Year Published

1997
1997
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 143 publications
0
5
0
Order By: Relevance
“…The latter has been studied extensively where it plays a major role in the development of drug resistance in both tumorigenic cells and cultured cell lines [2]. This occurs by the drug selecting for cells that carry units of amplified DNA (amplicons) containing genes that confer resistance by increasing the production of either the drug's target protein or a protein that detoxifies it.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The latter has been studied extensively where it plays a major role in the development of drug resistance in both tumorigenic cells and cultured cell lines [2]. This occurs by the drug selecting for cells that carry units of amplified DNA (amplicons) containing genes that confer resistance by increasing the production of either the drug's target protein or a protein that detoxifies it.…”
Section: Introductionmentioning
confidence: 99%
“…This occurs by the drug selecting for cells that carry units of amplified DNA (amplicons) containing genes that confer resistance by increasing the production of either the drug's target protein or a protein that detoxifies it. Besides the beneficial gene, the amplicon may also contain other genes in usually at least 50 kb of flanking DNA [2]. Indeed, newly amplified genes may be contained in very large regions of DNA, tens of megabases long, which subsequently become more condensed [3].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, the occurring problem of drug resistance and metastatic spread makes reduces the effectiveness of standard therapeutic approaches, such as surgery, chemotherapy, and radiotherapy. It has been also noted that patients after chemotherapeutic protocols progressively develop genetic mutations (26)(27)(28). It may be a consequence of either activation of proto-oncogenes or inactivation of tumorsuppressor genes.…”
Section: Discussionmentioning
confidence: 99%
“…In fact, based on an analysis of several hundred different human cancers, it can be estimated that approximately 50% of human cancers will express the MDR1 gene at some time during therapy. 15 (Details about the cloning and genetic analysis of MDR genes can be found in reviews by Schoenlein 16,17 and Gottesman et al 4…”
mentioning
confidence: 99%